AMRX Other Income/Expenses (Net)
Amneal Pharmaceuticals Inc Class A · Other Income/Expenses (Net)
AMRX Other Income/Expenses (Net)
Latest reported-$202.06Mperiod ending
AMRX TTM Other Income/Expenses (Net) (-$73.78M → -$202.06M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
AMRX other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -202,057,000 | |
| -186,728,000 | |
| -186,895,000 | |
| -218,740,000 | |
| -287,020,000 | |
| -302,424,000 | |
| -304,339,000 | |
| -310,881,000 | |
| -290,186,000 | |
| -265,545,000 | |
| -244,644,000 | |
| -190,677,000 | |
| -180,159,000 | |
| -163,848,000 | |
| -153,199,000 | |
| -137,006,000 | |
| -125,391,000 | |
| -123,573,000 | |
| -121,350,000 | |
| -119,511,000 | |
| -113,277,000 | |
| -113,491,000 | |
| -126,935,000 | |
| -135,256,000 | |
| 27,618,000 | |
| 22,813,000 | |
| 28,440,000 | |
| 24,330,000 | |
| -166,201,000 | |
| -210,331,000 | |
| -183,049,000 | |
| -161,907,000 | |
| -162,295,000 | |
| -85,854,000 | |
| -73,780,000 | |
| -93,349,000 |